International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7951277
Original Article
A Retrospective Study of Lipid Profile in Hypothyroidism in a Tertiary Care Centrein Mandya
 ,
Published
May 19, 2023
Abstract
Background: Hypothyroidism is a common endocrine disorder associated with several metabolic abnormalities, including dyslipidemia. The prevalence of dyslipidemia in hypothyroidism and the effect of thyroid hormone replacement therapy on lipid profile are well-established. However, the association between lipid profile and age and sex in patients with hypothyroidism is less clear. Methods: We conducted a retrospective study of 100 patients with hypothyroidism to evaluate their lipid profile and investigate the effect of thyroid hormone replacement therapy on lipid levels. We also analyzed the association between lipid profile and age and sex in this patient population. Results: Our study found a high prevalence of dyslipidemia in patients with hypothyroidism, with elevated total cholesterol and LDL cholesterol being the most commonly observed abnormalities. Thyroid hormone replacement therapy significantly improved lipid profile values in patients with hypothyroidism, with a decrease of 20% in total cholesterol and 25% in LDL cholesterol. We also found an age-related increase in total cholesterol and LDL cholesterol and a decrease in HDL cholesterol, while HDL cholesterol was significantly lower and triglycerides were significantly higher in females. Conclusion: Our study highlights the importance of screening and monitoring lipid profile in patients with hypothyroidism, especially those who are older or female. Thyroid hormone replacement therapy significantly improves lipid profile values in patients with hypothyroidism. Age and sex are important factors that influence lipid profile in patients with hypothyroidism. Therefore, appropriate attention should be given to these factors when managing dyslipidemia in patients with hypothyroidism.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2886 Views
375 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved